Source: Genomeweb

Hain Lifescience: Bruker to Acquire Majority Stake in Infectious Disease MDx Firm Hain

Read full article »

Hain Lifescience's Competitors | Hain Lifescience's News | Hain Lifescience's Financials

Followers on Owler

6

Est. Annual Revenue

$25-100M

Est. Employees

25-100

General Manager

David Hain

CEO Approval Rating

80/100

Hain Lifescience develops molecular diagnosis and antibiotic resistance testing systems for the detection of microbial and viral pathogens.